Vera Maslova

535 posts

Vera Maslova banner
Vera Maslova

Vera Maslova

@veramasloo

EP enthusiast, University Hospital Kiel, Germany | Senior Reviewer @EHJCREiC | #EHRA_ESC E-comm committee | 🔴 Nucleus @youngDGK

Kiel, Germany Katılım Şubat 2021
783 Takip Edilen2.4K Takipçiler
Vera Maslova retweetledi
HeartRhythm
HeartRhythm@hrs_journal·
Revisiting the Link Between Substrate and Ventricular Tachycardia Rate: The Critical Role of Conduction Isthmus Structure and Function @guichard_jb @ivroca
HeartRhythm tweet media
English
0
28
51
6.4K
Vera Maslova retweetledi
Vera Maslova retweetledi
EHRAPresident
EHRAPresident@EHRAPresident·
🫀 #EHRAtopicweek | Vascular access in EP Landmarks alone can deceive you. At lower inguinal punctures, the femoral vein sits posterior to the artery (>50% overlap) in ~24% of cases — and fully lateral in 6%. That's why palpation-guided access carries a real AV-fistula risk. The fix? Ultrasound-guided access. Better success, fewer complications, especially in difficult or previously failed cases. Know the anatomy. Image the vessel. Puncture with confidence. 🎯 Read more 👉 bit.ly/4eTAp7w @escardio #EHRA_ESC
EHRAPresident tweet mediaEHRAPresident tweet mediaEHRAPresident tweet media
English
3
42
106
29.2K
Vera Maslova retweetledi
EHRAPresident
EHRAPresident@EHRAPresident·
Can Pulsed Field Ablation transform the treatment of ventricular arrhythmias? Join renowned experts @AndreaSarkozy, Josef Kautzner, and Frédéric Sacher for an insightful discussion on the opportunities, challenges, and future role of PFA beyond atrial fibrillation. Explore the latest evidence and clinical experience in ventricular arrhythmia ablation 🤔 📅 28 July 2026 ⏲️ 18:00–19:00 CEST Secure your place today 👉bit.ly/3S8zlVw #EHRA_ESC @escardio
English
0
8
17
2.3K
JICE
JICE@JICE_EP·
🚨Latest #FreeRead Article in @JICE_EP Impact of Catheter Design on Lesion Dimensions during Focal-Bipolar Pulsed Field Ablation: an in Vitro Potato Model Study 🧐📖rdcu.be/fhFnl by Łukasz Zarębski, Agata Wawrzyniak & @ftrae #EPeeps
JICE tweet media
Polski
1
9
21
2.4K
Syamkumar
Syamkumar@syamkumarmd·
37 yrs old male, with minimal symptoms and noted to have severe LV dysfunction. Normal Cath and LVEDP is 3!. What could be the coause and where do you localize the problem? #EPeeps
Syamkumar tweet mediaSyamkumar tweet mediaSyamkumar tweet media
English
7
10
40
6.2K
Vera Maslova
Vera Maslova@veramasloo·
@NikhilShahMD do you know, if the manuscript ia already published? can not find it
English
1
0
0
78
Nikhil Shah, MD
Nikhil Shah, MD@NikhilShahMD·
Great talk at #HRS2026 on OCT in the RCA following CTI PFA. Average ~10% reduction in RCA MLA with or without pre-existing CAD. I still use RF here for this concern but this is reassuring! Might make me reconsider #EPeeps
Nikhil Shah, MD tweet mediaNikhil Shah, MD tweet mediaNikhil Shah, MD tweet mediaNikhil Shah, MD tweet media
English
2
3
14
1.1K
Vera Maslova retweetledi
Chris Kowalewski MD
Chris Kowalewski MD@C_KowalewskiMD·
Bipolar ablation for VT does not have to be on the septum… @veramasloo ablating between endo and epicardium. @HRS
Chris Kowalewski MD tweet media
English
1
9
18
1.1K
Vera Maslova retweetledi
Chris Kowalewski MD
Chris Kowalewski MD@C_KowalewskiMD·
Always wondered how to map VT by stimulation? Very nice example by @ivroca on s1s2s3. Sucessively shorter coupled stimuly that lead to slower conduction and uncover functional block. See how both the absolute and relative delay increase depending on substrate.
Chris Kowalewski MD tweet media
English
0
6
16
1.3K
Vera Maslova retweetledi
Sandeep Gautam
Sandeep Gautam@gautamsand·
📢LBCT ASCEND CSP #HRS2026 (+ Simultaneous pub @hrs_journal) @rdschaller @Drdevignair @pvijayaraman1 @HRSonline #SciComms *⃣Another step toward true physiologic ICD therapy: 👉 A purpose-built, stylet-driven CSP ICD lead by Abbott for LBBAP ➡️Prospective, global IDE trial (n=205) • Implant success: 98.5% • LBBAP achieved: 99% (86% true/likely LBB capture) • Primary effectiveness: 94.6% (exceeded 80% goal) • Stable thresholds + sensing at 3 months ➡️Defibrillation performance (critical for ICD adoption): • 100% DFT success • 92.5% terminated with single 20J shock 👉 No compromise in shock efficacy despite septal lead position ➡️Safety signal: • 97.5% complication-free at 3 months • Events included: – 2 lead dislodgements – 1 septal perforation (LV entry, required lead removal) – 1 helix mechanical failure – 1 drop in R-wave amplitude ➡️Clinical Implication: ✴️This is the first dedicated, stylet-driven bipolar ICD lead engineered for CSP, specifically modified for septal/LBBA implantation ✴️Potential to enable physiologic ICD or LOT-CRT ⚠️ Caveats: • Single-arm (no RV lead comparator) • Short follow-up (3 months) • Operator-dependent CSP success • Unknown long-term durability, extractability, and TR impact heartrhythmjournal.com/article/S1547-…
Sandeep Gautam tweet mediaSandeep Gautam tweet mediaSandeep Gautam tweet mediaSandeep Gautam tweet media
English
1
13
38
4.2K
Vera Maslova retweetledi
Chris Kowalewski MD
Chris Kowalewski MD@C_KowalewskiMD·
Happy to be invited to discuss the Proton late breakers with Dr. Lloyd and @KarimBenali42. It’s different to photons as it delivers right to the spot. Looking forward to more proton data.
Chris Kowalewski MD tweet media
English
0
2
10
683
Vera Maslova
Vera Maslova@veramasloo·
#LBCT #HRS2026 @HRSonline Proton beam radio ablation for refractoryVT by @konsiont ➡️first in human,prospective,non-randomised ➡️scar-mediated VT,all had previous Ablation+AAD fail 👨‍🦱7pts,4 NICM,1ICM,2mixed ❗️FU 17 mo, 79%reduction in VTevents 🧷No SAEs; 5of 7died/Transplant
Vera Maslova tweet mediaVera Maslova tweet mediaVera Maslova tweet mediaVera Maslova tweet media
English
0
6
17
1.2K
Vera Maslova
Vera Maslova@veramasloo·
#LBCT #HRS2026 @HRSonline Early US experience of VT ablation with Sphere-9 @Osama_Dasa @Dr_Santangeli 👨‍🦱59pts (VT n=50,PVC n=9) 🎯RFA first line,PFA adjunctive in dense scar, epi-PFA only, no PFA in border zone ✅VT-non ind. 78%; VT free at 6 mo 70% ❗️complications 5%
Vera Maslova tweet mediaVera Maslova tweet mediaVera Maslova tweet mediaVera Maslova tweet media
English
2
13
21
3.2K
Vera Maslova
Vera Maslova@veramasloo·
#LBCT on #HRS2026 @HRSonline by Saurabh Kumar CAAD-VT Trial: ablation vs AAD in ICM&NICM 🌎Multicenter,randomized,9centers in Australia 🔚endpoint: free from VT, VT storm,death 👨‍🦱100pts,48%ICM,52%NICM on FU 36mo, ablation: REDUCED RISK OF COMPOSITE ENDPOINT vs AAD (51%vs71%)
Vera Maslova tweet mediaVera Maslova tweet mediaVera Maslova tweet mediaVera Maslova tweet media
English
1
18
33
6.3K
Vera Maslova
Vera Maslova@veramasloo·
#LBCT on #HRS2026! FULCRUM-VT trial:Ultra-low temperature VT ablation by @atulverma_md 🌎209 pts, 19 sites,2/3 ICM,1/3NICM 🧷safety endpoint:2.4% 🎯acute effectiveness 98% ✅chronic effectiveness:59%freedom from VT/AAD escalation, no difference ICMvs NICM ⬇️of VT burden,VTshocks
Vera Maslova tweet mediaVera Maslova tweet mediaVera Maslova tweet mediaVera Maslova tweet media
English
1
12
18
4.7K